Type to search

MD Anderson and Obsidian Therapeutics Announce FDA Clearance of IND Application for Novel TIL Therapy Obx-115 | Pharmtech Focus
Obsidian Therapeutics Appoints Lee Giguere, J.D., as Chief Legal Officer and Corporate Secretary | Pharmtech Focus
Obsidian Therapeutics Appoints Maria Fardis, Ph.D., to Board of Directors | Pharmtech Focus